Stay updated with breaking news from Boris Schmidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"A lot of conversations were around, how far do we take this?" says "Airbender" producer Jabbar Raisani, who talked shop with several colleagues
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia ("VT") and atrial fibrillation ("AF"), today announced CE Mark approval of its ultra-low temperature cryoablation ("ULTC") system for the treatment of monomorphic ventricular tachycardia. The system consists of the upgraded cryoablation console, also capable of supporting atrial ablation procedures using commercially available iCLAS™ catheters, and the vCLAS™ ventricular cryoablation catheter
In the EU-PORIA real-world registry of patients with atrial fibrillation who underwent pulsed field ablation, most patients did not have recurrence at 1 year and the learning curve for operators was quick. “EU-PORIA reflects data coming from seven European centers,” Boris Schmidt, MD, professor of medicine at Cardioangiologisches Centrum Bethanien in Frankfurt, Germany, told Healio.
Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter.
/PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of the HELIOSTAR™ Balloon Ablation Catheter –...